跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,493 条关于
“IL-23 inhibitors”
全部
18,493
临床试验
7,948
药物
3,995
机构
150
资讯
6,400
去年
FDA Approves Two IL-23 Inhibitors for Crohn's Disease as Gastroenterology Advances in 2025
去年
IL-17 and IL-23 Inhibitors Show Promising Safety and Efficacy Profiles in Elderly Psoriasis Patients
去年
IL-23 Inhibitors from J&J and Lilly Show Efficacy in Crohn's Disease Trials
去年
QX004N, an IL-23 Inhibitor, Demonstrates Promising Efficacy and Safety in Plaque Psoriasis Trial
去年
J&J's Tremfya and Lilly's Omvoh Demonstrate Efficacy in Crohn's Disease Phase III Trials
去年
Spyre Therapeutics Initiates Phase 1 Trial of Novel Long-Acting IL-23 Antibody for IBD Treatment
9个月前
Tildrakizumab Demonstrates Sustained Safety Profile Over Four Years in Psoriatic Arthritis Extension Study
去年
J&J's Oral IL-23 Inhibitor Icotrokinra Achieves Positive Phase 3 Results in Psoriasis
去年
Biologic Therapies Show Favorable Cancer Safety Profile in Psoriatic Disease Patients
去年
Risankizumab and Guselkumab Show Comparable Efficacy in Real-World Psoriasis Treatment Over One Year
第 1 页,共 640 页
上一页
下一页